scorecard

You Searched For "lancet infectious diseases" and got 18 results


Sort By:


Business Insider Latest Story Image
2 mins read

Pfizer's new bivalent mRNA Covid booster vax highly effective: Lancet

US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effec…

Business Insider Latest Story Image
2 mins read

'Long flu': Study finds influenza symptoms can linger like long Covid

People hospitalised with seasonal influenza also can suffer long-term, negative health effects, esp…

Business Insider Latest Story Image
2 mins read

CDC report shows woman diagnosed with Monkeypox delivers a healthy baby in US

The officials noted that the baby was delivered safely and both are "doing well", CBS news reported…

Business Insider Latest Story Image
2 mins read

One out of four people experienced mild side effects like headache, fatigue after receiving Pfizer or AstraZeneca COVID-19 vaccine

One in four people experience mild, short lived systemic side effects like headache, fatigue and te…

Business Insider Latest Story Image
3 mins read

The amount of coastal water that can harbor harmful Vibrio bacteria has spiked 56%. One species is flesh-eating.

There's been a 56% increase in the coastal waters where bacteria that can cause severe infections t…

Erin Schumaker   


Business Insider Latest Story Image
2 mins read

A new study documents first human-to-dog transmission of Monekypox virus in France

Twelve days after the onset of monkeypox symptoms, their male Italian greyhound, aged 4 years …

Business Insider Latest Story Image
3 mins read

One in eight patients develop long Covid symptoms says Lancet study

One in eight adults who are infected with the SARS-CoV-2 virus experience long term symptoms due to…

PTI   


Business Insider Latest Story Image
4 mins read

SIMPLY PUT: All you need to know to keep yourself safe from the newly emerging diseases

A new infection named Tomato flu has been reported from Kerala, Tamil Nadu, Haryana, and…

Business Insider Latest Story Image
3 mins read

Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study

The results of an interim study recently published in The Lancet showed that two doses of Covaxi…

PTI   


Business Insider Latest Story Image
3 mins read

India's Covaxin 77.8% effective for COVID-19, says Lancet Report

A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…

Business Insider Latest Story Image
2 mins read

Switzerland's infectious disease chief says children under age 10 can hug their grandparents. Not all experts agree.

Switzerland is lifting social distancing rules to allow children to hug their grandparents. Some re…

Shira Feder   


Business Insider Latest Story Image
3 mins read

Covaxin phase two data shows vaccine safe, induces immune response, says Lancet study

Covaxin had initially raised concerns among experts over its emergency approval by India's dr…

PTI   


Business Insider Latest Story Image
2 mins read

Tocilizumab can reportedly improve hospital survival in critically ill COVID-19 patients, says study

A drug normally used in rheumatoid arthritis and cancer treatments -- tocilizumab -- improves hospi…

Business Insider Latest Story Image
5 mins read

Rhea Mahbubani   


Business Insider Latest Story Image
3 mins read

The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study

Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID)…

Business Insider Latest Story Image
2 mins read

China's COVID-19 vaccine is safe, prompts antibody response, says a Lancet study

A previous clinical trial reported similar results for a different vaccine that is also based on…

Business Insider Latest Story Image
3 mins read

COVID-19 spreads easily among people who live together: Lancet study

The study of people living together and family members -- not living at the same address -- and no…

PTI   


Business Insider Latest Story Image
3 mins read

Extensive contact tracing, isolation key to control COVID-19 spread: Lancet Study

However, the researchers from the Harbin Institute of Technology at Shenzhen, China, caution that …

PTI